Investment opportunities

17
days remaining
Target
€2.300.000
Invested
80.7%

OxyPrem AG

flag

OxyPrem's sensors help to protect prematurely-born children from brain damage and life-long disabilities.

40
days remaining
Target
€1.000.000
Invested
62.1%

Biointaxis

flag

Biointaxis develops and brings to market gene therapies for neurological diseases.

53
days remaining
Target
€2.000.000
Invested
75.2%

Pharmamel

flag

Development of new melatonin-based drugs for sepsis, inflammatory, and viral diseases.

5
days remaining
Target
€300.000
Invested
73.3%

Dipneo

flag

The first CPR ventilation device suitable for all types of users in out-of-hospital cardiac arrest situations.

Successfully closed!
Target
€1.200.000
Invested
110.5%

Hemerion

flag

Hemerion develops unique light-based therapies to extend and save lives of cancer patients.

Successfully closed!
Target
€700.000
Invested
142.8%

Lumiris

flag

The embryo as you never saw it before

Successfully closed!
Target
€500.000
Invested
111.2%

MSInsight

flag

MSInsight utilizes cutting-edge DNA sequencing to deliver highly accurate cancer tests, ensuring precise diagnoses and tailored treatments.

Successfully closed!
Target
€500.000
Invested
111.9%

Open Stent Solution

flag

Your support extends beyond funding a device; it catalyzes a transformative shift in healthcare.

Successfully closed!
Target
€575.000
Invested
110.5%

Spinally

flag

Introducing FuturaLead: The miniaturized spinal cord implant for a pain-free life.

Successfully closed!
Target
€500.000
Invested
100.9%

Improfit.AI

flag

B2B SaaS solutions providing AI-powered computer vision tools for digitizing rehabilitation.

Successfully closed!
Target
€600.000
Invested
133.1%

Flomics

flag

Flomics is developing a liquid biopsy test that can detect cancer even before the first symptoms appear, everything out of a blood sample.

Successfully closed!
Target
€1.000.000
Invested
106.3%

Oncoheroes Biosciences Inc.

flag

The world's first biotech company dedicated exclusively to developing drugs for pediatric cancer.